(Q37832928)

24 August 2017

1 reference

title

Microarray-based gene expression studies in ovarian cancer. (English)

1 reference

24 August 2017

1 reference

Hye Sook Chon

1

1 reference

PubMed ID

21273975

24 August 2017

Johnathan M Lancaster

series ordinal

2

1 reference

24 August 2017

1 January 2011

1 reference

24 August 2017

1 reference

24 August 2017

18

1 reference

24 August 2017

8-15

1 reference

24 August 2017

1

1 reference

24 August 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Recent advances in the treatment of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Identification of interferon-modulated proliferation-related cDNA sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Yeast microarrays for genome wide parallel genetic and gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Gene expression patterns in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Fabrication of DNA microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Light-generated oligonucleotide arrays for rapid DNA sequence analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

A novel, high-performance random array platform for quantitative gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Diverse tumorigenic pathways in ovarian serous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Osteopontin as a potential diagnostic biomarker for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Overexpression of kallikrein 10 in epithelial ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Serum protein markers for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Gene expression patterns that characterize advanced stage serous ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Ovarian cancer: progress and continuing controversies in management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Influence of surgery and postoperative therapy and tumor characteristics on patient prognosis in advanced ovarian carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Molecular profiling of platinum resistant ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Genomic signatures to guide the use of chemotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481101800102

10.1177/107327481101800102

21 January 2018

Identifiers

DOI

0 references

PubMed ID

21273975

1 reference

PubMed ID

21273975